PURPOSE: To compare the efficacy of cabergoline (Cb2) and intravenous human albumin (HA) in the prevention of ovarian hyperstimulation syndrome. METHODS: In this randomized controlled trial study, 138 women who were at high risk for developing OHSS were randomly allocated into two groups. In Group one, 20 gr of HA 20% was infused over 1 h. Group two received 0.5 mg per day of Cb2 orally for 7 days, starting on oocyte pickup day. All patients were visited seven and 14 days after oocyte retrieval to determine early clinical or ultrasound evidence of OHSS. RESULTS:Moderate OHSS was observed in 33 versus 14 cases in the HA and Cb2 groups, respectively, which was significantly different. The number of severe OHSS cases in the HA group was significantly higher than in the Cb2 group (P < 0.001). CONCLUSIONS:Prophylactic oral low dose cabergoline was more effective and less costly than intravenous human albumin in the prevention of OHSS in high-risk patients.
RCT Entities:
PURPOSE: To compare the efficacy of cabergoline (Cb2) and intravenous human albumin (HA) in the prevention of ovarian hyperstimulation syndrome. METHODS: In this randomized controlled trial study, 138 women who were at high risk for developing OHSS were randomly allocated into two groups. In Group one, 20 gr of HA 20% was infused over 1 h. Group two received 0.5 mg per day of Cb2 orally for 7 days, starting on oocyte pickup day. All patients were visited seven and 14 days after oocyte retrieval to determine early clinical or ultrasound evidence of OHSS. RESULTS: Moderate OHSS was observed in 33 versus 14 cases in the HA and Cb2 groups, respectively, which was significantly different. The number of severe OHSS cases in the HA group was significantly higher than in the Cb2 group (P < 0.001). CONCLUSIONS: Prophylactic oral low dose cabergoline was more effective and less costly than intravenous human albumin in the prevention of OHSS in high-risk patients.
Authors: Mohamed A F M Youssef; Madelon van Wely; Mohamed Ahmed Hassan; Hesham Gaber Al-Inany; Monique Mochtar; Sherif Khattab; Fulco van der Veen Journal: Hum Reprod Update Date: 2010-03-30 Impact factor: 15.610
Authors: A Ben-Chetrit; T Eldar-Geva; M Gal; M Huerta; T Mimon; N Algur; Y Z Diamant; E J Margalioth Journal: Hum Reprod Date: 2001-09 Impact factor: 6.918
Authors: Raúl Gómez; Sergio R Soares; Cristiano Busso; Juan A Garcia-Velasco; Carlos Simón; Antonio Pellicer Journal: Semin Reprod Med Date: 2010-11-16 Impact factor: 1.303
Authors: A Z Isik; O Gokmen; H B Zeyneloglu; S Kara; G Keles; B Gulekli Journal: Eur J Obstet Gynecol Reprod Biol Date: 1996-12-27 Impact factor: 2.435
Authors: José Bellver; Elkin A Muñoz; Agustín Ballesteros; Sérgio Reis Soares; Ernesto Bosch; Carlos Simón; Antonio Pellicer; José Remohí Journal: Hum Reprod Date: 2003-11 Impact factor: 6.918